Biochemistry, Genetics and Molecular Biology
T Cell
100%
Synapse
100%
Transcriptomics
100%
SNP Genotyping
100%
Hedgehog Signaling Pathway
100%
Aurora Kinase
100%
YAP1
100%
PLK1
100%
Interferon Type I
100%
SUFU
100%
CHEK1
100%
Genomics
100%
Cyclin Dependent Kinase Inhibitor 2A
100%
Keyphrases
Tumor
100%
Vulnerability
100%
Malignant Pleural Mesothelioma
100%
Integrated Genomics
100%
Poor Survival
25%
Effective Therapy
25%
Therapeutic Target
25%
Malignancy
25%
T Cells
25%
New Therapeutics
25%
Synapse
25%
Type I Interferon
25%
Mesothelioma
25%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
25%
Hippo Pathway
25%
Transcriptomics
25%
Hedgehog Signaling Pathway
25%
Patient-derived Cell Line
25%
Aurora Kinase Inhibitor
25%
SNP Genotyping
25%
Therapeutic Avenues
25%
Verteporfin
25%
Yes-associated Protein 1 (YAP1)
25%
LATS1
25%
Biomarkers for Immunotherapy
25%
NF-2
25%
Mesothelioma Cells
25%
Codeletion
25%
Low Passage
25%
CHEK1
25%
PLK1 Kinase
25%
RASSF7
25%
Medicine and Dentistry
Pleura Mesothelioma
100%
Tumor
100%
Mesothelioma
50%
Cancer
25%
Immunotherapy
25%
Synapse
25%
Single Nucleotide Polymorphism
25%
Biological Marker
25%
T Cell
25%
Transcriptomics
25%
Hedgehog Signaling
25%
Interferon Type I
25%
Verteporfin
25%
Aurora Kinase Inhibitor
25%
Cyclin Dependent Kinase Inhibitor 2A
25%
Pharmacology, Toxicology and Pharmaceutical Science
Pleura Mesothelioma
100%
Mesothelioma
100%
Biological Marker
50%
Immunotherapy
50%
Interferon Type I
50%
Hedgehog
50%
Verteporfin
50%
Cyclin Dependent Kinase Inhibitor 2A
50%
Aurora Kinase Inhibitor
50%